Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation

Journal of Endocrinology

Volumn 157, Issue 2, 1998, Pages 225-235

  Robson, H ^b   Anderson, E ^b   Eden, O B ^b   Isaksson, O ^a   Shalet, S ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMETABOLITE; DACTINOMYCIN; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY HEIGHT; BONE GROWTH; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARTILAGE CELL; CELL DEATH; CELL PROLIFERATION; CHILDHOOD CANCER; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; EPIPHYSIS; GROWTH PLATE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT STATURE;

EID: 0031863992     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1570225     Document Type: Article

References (29)

1. Achterrath W, Nierdele N, Raettig R & Hilgard P 1982 Etoposide - Chemistry, pre-clinical and clinical pharmacology. Cancer Treatment Reviews 9 3-13.
2. Adamson PC, Poplack DG & Balis FM 1994 The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leukemia Research 18 805-810.
3. Baron J, Oerter Klein K, Colli MJ, Yanovski JA, Novosad JA, Bacher JD & Cutler GB 1994 Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate. Endocrinology 135 1367-1371.
4. Benya PD & Shaffer JD 1982 Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30 215-224.
5. Bokkerink JPM, Stet EH, Deabreu RA, Damen FJM, Hulscher TW, Bakker MAH & Van Baal JA 1993 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T lymphocytes. Biochemical Pharmacology 45 1455-1463.
6. Cancedda FD, Gentili C, Manduca P & Cancedda R 1992 Hypertrophic chondrocytes undergo further differentiation in culture. Journal of Cell Biology 117 427-435.
7. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JK & Shalet SM 1994 Disproportionate short stature following cranial irradiation and combination chemotherapy for leukaemia. Archives of Diseases in Childhood 70 472-475.
8. Falliers CJ, Szentivanyi J, Jorgensen JR & Vukantz SC 1963 Childhood asthma and steroid therapy have influences on growth. American Journal of Diseases in Childhood 105 127-137.
9. Hansson A, Hehenberger K & Thoren M 1996 Long term treatment of swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by IGF-I. Cell Biochemistry and function 14 121-129.
10. Hunziker EB 1994 Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microscopy Research Techniques 28 505-519.
11. Jaskiewicz K, Voight H & Blakolmer K 1996 Increased matrix proteins, collagen and transforming growth factor are early markers of hepatotoxicity in patients on long-term methotrexate therapy. Journal of Toxicology and Clinical Toxicology 34 301-305.
12. Kaspers GJ, Veermen AJ, Popp-Snijders C, Lomecky M, Van-Zantwijk CH, Swinkels LM, Van-Wering ER & Pieters R 1996 Comparison of the antileukaemic activity in vivo of dexamethasone and prednisolone in childhood acute lymphoblastic leukaemia. Medical and Pediatric Oncology 27 114-121.
13. Kember NF 1971 Growth hormone and cartilage cell division in hypophysectomised rats. Cell and Tissue Kinetics 4 193-199.
14. Le Page GA 1963 Basic biochemical effects and mechanisms of action of 6-thioguanine. Cancer Research 23 1202-1206.
15. Lindahl A, Isgaard J & Isaksson OGP 1987 GH in vivo potentiates the stimulatory effect of IGF-I in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomised rats. Endocrinology 121 1070-1075.
16. McCormack JJ & Johns DG 1982 Purine antimetabolites. In Pharmacologic Principles of Cancer Treatment, pp 213-228. Ed B Chabner. Philadelphia: WB Saunders.
17. Micetich KC, Barnes D & Erickson LC 1985 A comparative study of the cytotoxicity and DNA damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum (II) and cis-diamminedichloroplatinum (II) on L1210 cells. Cancer Research 45 4043-4047.
18. Morris MJ 1981 In vitro effects of anti-leukaemic drugs on cartilage metabolism and their effects on somatomedin production by the liver. PhD Thesis, Manchester University.
19. Ogilvy-Stuart AL & Shalet SM 1995 Growth and puberty after GH treatment after irradiation for brain tumours. Archives of Diseases in Childhood 73 141-146.
20. Olshan JS, Gubernick J, Packer RJ, D'Angio GJ, Goldwein JW, Willi SM & Moshang T 1992 The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70 2013-2017.
21. Pairault J & Lasnier F 1987 Control of the adipogenic differentiation of 3T3-F442A cells by retinoic acid, dexamethasone, and insulin: a topographic analysis. Journal of Cell Physiology 132 279-286.
22. Perry RP & Kelly DE 1970 Inhibition of RNA synthesis by actinomycin D: characteristic dose response of different RNA species. Journal of Cell Physiology 76 127.
23. Preston SJ, Diamond T, Scott A & Laurent MR 1993 Methotrexate osteopathy in rheumatic disease. Annals of the Rheumatic Diseases 52 582-585.
24. Price JS, Oyajobi BO & Russell RGG 1994 The cell biology of bone growth. European Journal of Clinical Nutrition 48 S131-S149.
25. Sherman SE, Gibson D, Wang AH & Lippard SJ 1985 X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]. Science 230 412-417.
26. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S & Boyd MR 1990 New colorimetric cytotoxicity assay for anticancer drug screening. Journal of the National Cancer Institute 82 1107-1112.
27. Van Metre Jr TE & Pinkerton Jr HL 1959 Growth suppression in asthmatic children receiving prolonged therapy with prednisone or methyl-prednisone. Journal of Allergy 30 103-113.
28. Van der Veen MJ, Scheven BAA, Van Roy JLAM, Damen CA, Lafeber FPJG & Bijlsma JWJ 1996. In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts. British Journal of Rheumatology 35 342-349.
29. 2 protocol chemotherapy. Cancer 45 p3034-p3039.